chr10-22209011-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394757.1(EBLN1):c.973A>T(p.Ile325Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,535,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394757.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000140 AC: 18AN: 128480Hom.: 0 AF XY: 0.000156 AC XY: 11AN XY: 70366
GnomAD4 exome AF: 0.000213 AC: 295AN: 1383546Hom.: 0 Cov.: 30 AF XY: 0.000218 AC XY: 149AN XY: 682678
GnomAD4 genome AF: 0.000164 AC: 25AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.973A>T (p.I325L) alteration is located in exon 1 (coding exon 1) of the EBLN1 gene. This alteration results from a A to T substitution at nucleotide position 973, causing the isoleucine (I) at amino acid position 325 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at